Literature DB >> 15735950

Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs: a clinicopathological study of ten autopsy cases.

Kuniaki Tsuchiya1, Shigeo Murayama, Kazuko Mitani, Tatsuro Oda, Kunimasa Arima, Masaru Mimura, Hiroshi Nagura, Chie Haga, Haruhiko Akiyama, Hiroshi Yamanouchi, Hidehiro Mizusawa.   

Abstract

This report concerns a clinicopathological study of three additional patients with corticobasal degeneration (CBD), described here for the first time, and a clinicopathological correlation between pyramidal signs and upper motor neuron involvement, in ten autopsy cases of CBD, including seven cases reported by us previously. We investigated pyramidal signs, including hyperreflexia, Babinski sign, and spasticity, and involvement of the primary motor cortex and pyramidal tract, focusing on the astrocytosis of the fifth layer of the primary motor cortex. Pyramidal signs were observed in six (60%) of the ten cases. Hyperreflexia was evident in six patients (60%), with spasticity being observed in three patients (30%). Loss of Betz cells associated with prominent astrocytosis and presence of ballooned neurons in the fifth layer of the primary motor cortex was observed in all ten cases. In all cases, involvement of the pyramidal tract was obvious in the medulla oblongata, without involvement of the pyramidal tract in the midbrain. Constant and severe involvement of the fifth layer of the primary motor cortex, including the Betz cells, has not previously been reported in CBD. We suggest that the pyramidal signs in CBD have been disregarded.

Entities:  

Mesh:

Year:  2005        PMID: 15735950     DOI: 10.1007/s00401-004-0966-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Magnetic resonance imaging corticospinal tract hyperintensities in progressive supranuclear palsy.

Authors:  David W Van Wyck; Jonathan R Diaz; Yince Loh
Journal:  Neurohospitalist       Date:  2015-04

2.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

4.  Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia.

Authors:  Keith A Josephs; Jennifer L Whitwell; Melissa E Murray; Joseph E Parisi; Neill R Graff-Radford; David S Knopman; Bradley F Boeve; Matthew L Senjem; Rosa Rademakers; Clifford R Jack; Ronald C Petersen; Dennis W Dickson
Journal:  Brain       Date:  2013-01-28       Impact factor: 13.501

5.  Poststroke cerebral peduncular atrophy correlates with a measure of corticospinal tract injury in the cerebral hemisphere.

Authors:  V W Mark; E Taub; C Perkins; L V Gauthier; G Uswatte; J Ogorek
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-16       Impact factor: 3.825

6.  Imaging of corticobasal degeneration syndrome.

Authors:  Masamichi Koyama; Akira Yagishita; Yasuhiro Nakata; Masaharu Hayashi; Mitsuaki Bandoh; Toshio Mizutani
Journal:  Neuroradiology       Date:  2007-07-14       Impact factor: 2.804

7.  Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.

Authors:  Helen Ling; H Ling; R de Silva; L A Massey; R Courtney; G Hondhamuni; N Bajaj; J Lowe; J L Holton; A Lees; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2014-02       Impact factor: 8.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.